We are live on
!
Find out more
PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
150 hedge funds and large institutions have $318M invested in PDL BioPharma, Inc. in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 63 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
206% more call options, than puts
Call options by funds: $459K | Put options by funds: $150K
63% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 16
49% more capital invested
Capital invested by funds: $214M → $318M (+$104M)
7% more funds holding
Funds holding: 140 → 150 (+10)
48% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 63
Holders
150
Holders Change
+10
Holders Change %
+7.14%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
33
Reduced
63
Closed
16
Calls
$459K
Puts
$150K
Net Calls
+$309K
Net Calls Change
+$165K
Top Buyers
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.13M |
| 2 |
Morgan Stanley
New York
|
-$3.85M |
| 3 |
Renaissance Technologies
New York
|
-$3.47M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.45M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$2.1M |
